Package | us.nlm.vsac |
Type | ValueSet |
Id | 2.16.840.1.113883.3.1444.5.244 |
FHIR Version | R4 |
Source | http://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113883.3.1444.5.244/expansion |
URL | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.5.244 |
Version | 20241010 |
Status | active |
Date | 2024-10-10T01:07:42-04:00 |
Name | AnthracyclineInjectable |
Title | Anthracycline Injectable |
Realm | us |
Authority | hl7 |
Description | Used in: #1045 |
Purpose | (Clinical Focus: The purpose of this value set is to represent concepts of medication anthracycline.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent a medication anthracycline; generic; prescribable; injectable.),(Exclusion Criteria: Excludes concepts that represent non-prescribable branded drugs, components or ingredients.) |
No resources found
CodeSystem | |
rxnorm | RxNorm |
rxnorm | RxNorm |
ValueSet | |
2.16.840.1.113762.1.4.1116.168 | Doxorubicin Injectable |
2.16.840.1.113762.1.4.1116.200 | Epirubicin Injectable |
2.16.840.1.113762.1.4.1116.332 | Daunorubicin Injectable |
2.16.840.1.113883.3.1444.3.153 | Idarubicin Injectable |
2.16.840.1.113883.3.1444.3.167 | Mitoxantrone Injectable |
2.16.840.1.113883.3.1444.3.197 | Doxorubicin Pegylated Liposomal Injectable |
No narrative content found in resource